(ERIE) Erie Indemnity - NASDAQ
Sector: Financial Services | Industry: Insurance Brokers | Exchange: NASDAQ (USA) | Market Cap: 11.818m USD | Total Return: -35.6% in 12m
Avg Turnover: 38.8M
EPS Trend: 94.6%
Qual. Beats: 0
Rev. Trend: 97.7%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Erie Indemnity Company (ERIE) serves as the managing attorney-in-fact for the Erie Insurance Exchange, a reciprocal insurer. In this specialized role, the company performs critical operational functions including policy issuance, underwriting, billing, and claims processing in exchange for management fees.
The company’s business model is distinct from standard insurers because it generates revenue through service fees rather than assuming the primary underwriting risk of the insurance policies themselves. As a constituent of the Property & Casualty Insurance sector, Erie Indemnity relies on a network of independent agents to drive policy growth and retention across its geographic footprint.
For a deeper look into the companys valuation metrics and historical performance, consider reviewing the data available on ValueRay. Founded in 1925 and headquartered in Pennsylvania, Erie Indemnity maintains a long-standing operational history within the regional insurance market.
- Management fee revenue scales with Erie Insurance Exchange direct written premium growth
- Independent agent network expansion drives market share gains in core regions
- Rising loss costs for the Exchange pressure management fee rate stability
- Investment income volatility impacts net income and shareholder dividend capacity levels
- Regulatory changes in Pennsylvania and Ohio affect regional insurance pricing flexibility
| Net Income: 571.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.16 > 0.02 and ΔFCF/TA -1.28 > 1.0 |
| NWC/Revenue: 4.72% < 20% (prev 7.95%; Δ -3.22% < -1%) |
| CFO/TA 0.20 > 3% & CFO 660.4m > Net Income 571.4m |
| Net Debt/EBITDA: error (cannot be calculated) |
| Current Ratio: 1.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (52.7m) vs 12m ago -9.79% < -2% |
| Gross Margin: 16.12% > 18% (prev 17.65%; Δ -1.53% > 0.5%) |
| Asset Turnover: 128.9% > 50% (prev 131.5%; Δ -2.59% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.06 (Total Current Assets 1.14b - Total Current Liabilities 942.5m) / Total Assets 3.38b |
| B: 1.05 (Retained Earnings 3.55b / Total Assets 3.38b) |
| C: 0.23 (EBIT TTM 726.2m / Avg Total Assets 3.17b) |
| D: 2.30 (Book Value of Equity 2.35b / Total Liabilities 1.02b) |
| Altman-Z'' = 7.75 = AAA |
| DSRI: 0.99 (Receivables 757.7m/730.7m, Revenue 4.09b/3.90b) |
| GMI: 1.09 (GM 17.65% / 16.12%) |
| AQI: 1.10 (AQ_t 0.49 / AQ_t-1 0.45) |
| SGI: 1.05 (Revenue 4.09b / 3.90b) |
| TATA: -0.03 (NI 571.4m - CFO 660.4m) / TA 3.38b) |
| Beneish M = -2.86 (Cap -4..+1) = A |
As of June 13, 2026, the stock is trading at USD 226.67 with a total of 136,331 shares traded.
Over the past week, the price has changed by -0.24%,
over one month by +3.74%,
over three months by -6.19% and
over the past year by -35.59%.
Erie Indemnity has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy ERIE.
- StrongBuy: 1
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 115 | -49.3% |
P/E Trailing = 20.678
P/E Forward = 26.738
P/S = 2.8897
P/B = 5.1541
P/EG = 2.6718
Revenue TTM = 4.09b USD
EBIT TTM = 726.2m USD
EBITDA TTM = 799.8m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 11.5b USD (11.8b + (null Debt) - CCE 338.3m)
Interest Coverage Ratio = unknown (Ebit TTM 726.2m / Interest Expense TTM 0.0)
EV/FCF = 21.38x (Enterprise Value 11.5b / FCF TTM 537.0m)
FCF Yield = 4.68% (FCF TTM 537.0m / Enterprise Value 11.5b)
FCF Margin = 13.13% (FCF TTM 537.0m / Revenue TTM 4.09b)
Net Margin = 13.97% (Net Income TTM 571.4m / Revenue TTM 4.09b)
Gross Margin = 16.12% ((Revenue TTM 4.09b - Cost of Revenue TTM 3.43b) / Revenue TTM)
Gross Margin QoQ = 14.52% (prev 14.59%)
Tobins Q-Ratio = 3.40 (Enterprise Value 11.5b / Total Assets 3.38b)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.32% (154.8m / 726.2m)
NOPAT = 571.4m (EBIT 726.2m * (1 - 21.32%))
Current Ratio = 1.20 (Total Current Assets 1.14b / Total Current Liabilities 942.5m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 799.8m)
Debt / FCF = unknown (Net Debt none / FCF TTM 537.0m)
Total Stockholder Equity = 2.28b (last 4 quarters mean from totalStockholderEquity)
RoA = 18.01% (Net Income 571.4m / Total Assets 3.38b)
RoE = 25.03% (Net Income TTM 571.4m / Total Stockholder Equity 2.28b)
RoCE = 29.83% (EBIT 726.2m / Capital Employed (Total Assets 3.38b - Current Liab 942.5m))
RoIC = 25.63% (NOPAT 571.4m / Invested Capital 2.23b)
WACC = 5.46% (E(11.8b)/V(11.8b) * Re(5.46%) + (debt-free company))
Discount Rate = 5.46% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 31.46 | Cagr: 0.00%
[DCF] Terminal Value 76.11% ; FCFF base≈526.2m ; Y1≈551.5m ; Y5≈636.5m
[DCF] Fair Price = 212.4 (EV 9.81b - Net Debt 0.0 = Equity 9.81b / Shares 46.2m; r=8.35% [WACC [floored]]; 5y FCF grow 5.27% → 2.50% )
EPS Correlation: 94.57 | EPS CAGR: 22.72% | SUE: -0.46 | # QB: 0
Revenue Correlation: 97.65 | Revenue CAGR: 12.09% | SUE: 4.0 | # QB: 1
EPS current Quarter (2026-06-30): EPS=3.35 | Chg30d=-6.16% | Revisions=-20% | Analysts=1
EPS next Quarter (2026-09-30): EPS=3.46 | Chg30d=-5.21% | Revisions=-20% | Analysts=1
EPS current Year (2026-12-31): EPS=12.64 | Chg30d=-6.44% | Revisions=-20% | GrowthEPS=+3.2% | GrowthRev=+2.7%